6 completed, 5 unknown, 2 withdrawn, 1 recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 6, Unknown 5, Withdrawn 2, Recruiting 1 |
Follow Metal Metabolism, Inborn Errors: new trials by email Literature Review of Metal Metabolism, Inborn Errors trials Research Report on Metal Metabolism, Inborn Errors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia methotrexate, rituximab, bortezomib - Hypophosphatasia | Phase 4 | Withdrawn | Alexion Pharmaceuticals, Inc. | 2026-07-29 | 2025-12-18 | |
| Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy Niferex - Iron Deficiency Anemia of Pregnancy, Iron Storage Disease | Phase 4 | Unknown | Qianfoshan Hospital | 452 | 2023-03-28 | 2023-04-07 |
| Gandouling in the Treatment of Wilson's Disease Gandouling - Wilson's Disease | Phase 4 | Unknown | Jun Li | 240 | 2023-01-01 | 2024-02-09 |
| Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH KRN23 - X-linked Hypophosphatemia (XLH) | Phase 4 | Completed | Kyowa Kirin Co., Ltd. | 28 | 2021-11-01 | 2024-07-09 |
| Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH KRN23 - X-linked Hypophosphatemia (XLH) | Phase 4 | Completed | Kyowa Kirin Co., Ltd. | 18 | 2021-09-28 | 2024-07-09 |
| Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease asfotase alfa - Hypophosphatasia | Phase 4 | Withdrawn | Alexion Pharmaceuticals, Inc. | 2020-04-01 | 2020-06-04 | |
| Examining the Effect of Burosumab on Muscle Function Burosumab Injection [Crysvita] - X-linked Hypophosphatemia | Phase 4 | Completed | Yale University | 10 | 2019-11-13 | 2023-08-24 |
| Effect of Theophylline in Pseudohypoparathyroidism Theophylline - PHP Ia, PHP IB | Phase 4 | Recruiting | Massachusetts General Hospital | 100 | 2019-11-11 | 2022-07-22 |
| Burosumab in Children and Adolescents With X-linked Hypophosphatemia Burosumab Injection - Rare Diseases, X-linked Hypophosphatemia | Phase 4 | Unknown | Bicetre Hospital | 57 | 2018-03-18 | 2020-06-05 |
| Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia Calcitriol - X-linked Hypophosphatemia | Phase 4 | Unknown | Peking Union Medical College Hospital | 100 | 2017-01-01 | 2019-01-30 |
| Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine trientine dihydrochloride - Wilson Disease | Phase 4 | Unknown | Univar BV | 90 | 2016-01-01 | 2017-08-23 |
| Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan Asfotase Alfa - Hypophosphatasia | Phase 4 | Completed | Alexion Pharmaceuticals, Inc. | 13 | 2015-06-01 | 2017-05-08 |
| Efficacy Study in Removing Excess Iron From the Heart Ferriprox (deferiprone), Desferal (deferoxamine) - Thalassemia Major, Hemosiderosis | Phase 4 | Completed | ApoPharma | 60 | 2002-12-01 | 2016-01-05 |
| Study of Zinc for Wilson Disease zinc acetate - Wilson Disease | Phase 4 | Completed | National Center for Research Resources (NCRR) | 300 | 1993-10-01 | 2005-06-24 |
Familial Hypophosphatemic Rickets (5) · Hepatolenticular Degeneration (3) · Hypophosphatasia (3) · Hemochromatosis (2) · Rare Diseases (2) · Bone Diseases (1) · Hemosiderosis (1) · Hyperparathyroidism (1) · Iron Overload (1) · Metabolism, Inborn Errors (1) · Osteomalacia (1) · Pseudohypoparathyroidism (1) · Pseudohypoparathyroidism Type 1C (1) · Rickets (1) · Thalassemia (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14) · Genetic Diseases, Inborn (14) · Metabolic Diseases (14) · Nutritional and Metabolic Diseases (14) · Metabolism, Inborn Errors (13) · Bone Diseases, Metabolic (7) · Calcium Metabolism Disorders (7) · Musculoskeletal Diseases (7) · Avitaminosis (6) · Bone Diseases (6) · Deficiency Diseases (6) · Malnutrition (6) · Nutrition Disorders (6) · Vitamin D Deficiency (6)
burosumab (4) · asfotase alfa (2) · Bortezomib (1) · Calcitriol (1) · Deferiprone (1) · Deferoxamine (1) · Folic Acid (1) · Immunoglobulins, Intravenous (1) · Methotrexate (1) · Niferex (1) · Rituximab (1) · Theophylline (1) · Trientine (1) · Zinc Acetate (1) · gluconic acid (1)
Alexion Pharmaceuticals, Inc. (3) · Kyowa Kirin Co., Ltd. (2) · ApoPharma (1) · Bicetre Hospital (1) · Jun Li (1) · Massachusetts General Hospital (1) · National Center for Research Resources (NCRR) (1) · Peking Union Medical College Hospital (1) · Qianfoshan Hospital (1) · Univar BV (1) · Yale University (1)
China (5) · United States (3) · Greece (2) · Italy (2) · France (1) · Germany (1) · United Kingdom (1)
Antonio Piga, M.D. (1) · George J. Brewer (1) · Karl L Insogna, M.D. (1) · Karl-Heinz Weiss, MD (1) · Kenji Fujita, MD (1) · Markissia Karagiorga, M.D. (1) · Renzo Galanello, M.D. (1) · Vassilis Ladis, M.D. (1) · Zhang Zhiwei, PH.D (1)